Immunotherapy biomarker discovery could benefit thousands with Type 1 diabetes

10 August 2020

Research led by Professor Lucy Walker (UCL Institute of Immunity & Transplantation) has discovered biomarkers which may identify people with Type 1 diabetes who would benefit from the immunotherapy drug Abatacept, which could help thousands manage the disease more effectively.